- Report
- October 2024
- 167 Pages
Europe
From €3270EUR$3,450USD£2,732GBP
- Report
- February 2022
- 80 Pages
Global
From €2606EUR$2,750USD£2,178GBP
€5213EUR$5,500USD£4,355GBP
- Report
- March 2022
- 300 Pages
Global
From €4739EUR$5,000USD£3,959GBP
- Report
- April 2023
- 275 Pages
Global
From €3782EUR$3,990USD£3,159GBP
- Report
- October 2023
- 171 Pages
Global
From €4265EUR$4,500USD£3,563GBP
- Report
- March 2023
- 115 Pages
Global
From €4265EUR$4,500USD£3,563GBP
- Report
- August 2023
- 166 Pages
Global
From €7109EUR$7,500USD£5,939GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1422EUR$1,500USD£1,188GBP
- Report
- August 2023
- 80 Pages
Global
From €3744EUR$3,950USD£3,128GBP
- Report
- February 2023
- 220 Pages
Global
From €7109EUR$7,500USD£5,939GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €3080EUR$3,250USD£2,573GBP
- Report
- September 2022
- 140 Pages
Global
From €3744EUR$3,950USD£3,128GBP
- Report
- August 2020
- 80 Pages
Global
From €3080EUR$3,250USD£2,573GBP
- Report
- April 2023
- 100 Pages
Global
From €4502EUR$4,750USD£3,761GBP
- Report
- April 2024
- 30 Pages
Global
From €3080EUR$3,250USD£2,573GBP
- Report
- April 2024
- 30 Pages
Global
From €3080EUR$3,250USD£2,573GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1896EUR$2,000USD£1,584GBP
- Clinical Trials
- April 2024
- 90 Pages
Global
From €1896EUR$2,000USD£1,584GBP
- Clinical Trials
- April 2024
- 50 Pages
Global
From €1422EUR$1,500USD£1,188GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1185EUR$1,250USD£990GBP

The Lipoprotein market is a subset of the biotechnology industry that focuses on the development of drugs and treatments related to lipoproteins. Lipoproteins are molecules composed of proteins and lipids that are responsible for transporting cholesterol and other lipids throughout the body. Lipoproteins are essential for maintaining healthy cholesterol levels and are involved in many metabolic processes.
The Lipoprotein market is driven by the increasing prevalence of cardiovascular diseases, such as atherosclerosis, and the need for effective treatments. Additionally, the development of new technologies and the increasing availability of data are driving the growth of the Lipoprotein market.
Some of the major companies in the Lipoprotein market include Amgen, AstraZeneca, Merck, Pfizer, and Sanofi. These companies are involved in the development of drugs and treatments related to lipoproteins, as well as the research and development of new technologies. Show Less Read more